CYP1A2 and metabolic dysfunction-associated steatotic liver disease: Likewise, nonalcoholic fatty liver disease (NAFLD) was associated with decreased mRNA, protein amount, and functional activity of microsomal CYP1A2 compared to healthy liver tissue [75].